Our Sites

The JHUBI-CTU integrates 3 highly productive Clinical Research Sites.

All three provide top-quality clinical care and clinical research at the same facility. Our sites are in urban areas most greatly affected by the HIV epidemic, and include the largest HIV clinic in Baltimore, India’s second largest HIV clinic, and YRGCARE CRS.  The JHUBI-CTU optimizes patient-oriented research and access to key populations affected by the HIV epidemic for participation in clinical trials.

The links above provide details about each site.

Clinical Trials

P1078: A Phase IV Randomized Double-Blind Placebo-Controlled...

P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...

Read More

NWCS 414, Evaluation of a Serum Biosignature for Identifying...

We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...

Read More

A5322: Long-Term Follow-up of Older HIV-infected Adults in...

The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...

Read More

A5350: Effects of Visbiome Extra Strength on Gut Microbiome...

Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...

Read More

P1077FF: Formula Feeding Version of the PROMISE Study...

1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More